Guideline Recommendations for Tapering and Discontinuation of Mirtazapine

Withdrawal Symptoms

Abrupt cessation of mirtazapine can precipitate agitation and anxiety, highlighting the need for a gradual taper. – American Family Physician (2002) 1

The general recommendation for antidepressant discontinuation is to taper the dose over 10–14 days to minimize withdrawal effects; this guideline is explicitly applied to mirtazapine. – American Family Physician (2002) 1
After 9 months of continuous therapy, clinicians should consider a dosage reduction to reassess the necessity of ongoing treatment. – American Family Physician (2002) 1

For a first episode of major depressive disorder, treatment should continue for at least 4 months before contemplating discontinuation; recurrent depression may require a longer maintenance period. – American Family Physician (2015) 3

Prior to initiating mirtazapine, patients should be informed about the possibility of withdrawal symptoms and the importance of a supervised taper. – American Academy of Sleep Medicine (Journal of Clinical Sleep Medicine, 2008) 4
When mirtazapine is prescribed for insomnia, integrating cognitive‑behavioral therapy for insomnia (CBT‑I) can facilitate a smoother taper and reduce withdrawal risk. – American Academy of Sleep Medicine (Journal of Clinical Sleep Medicine, 2008) 4